In its letter, the FDA claims that 23andMe ???had not even started other studies necessary to support a marketing submission.??? The agency was concerned that 23andMe???s results were not clinically accurate ??? and the firm was delivering false positive results to customers on over 254 diseases and conditions, including Alzheimer???s and Parkinson???s diseases.